Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance

Citation
K. Noda et al., Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance, EUR J PHARM, 415(2-3), 2001, pp. 209-216
Citations number
33
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
415
Issue
2-3
Year of publication
2001
Pages
209 - 216
Database
ISI
SICI code
0014-2999(20010316)415:2-3<209:ROENOI>2.0.ZU;2-O
Abstract
Mechanisms underlying celiprolol-induced vasodilatation were analyzed in is olated porcine coronary arteries. Celiprolol induced dose-related relaxatio n of the artery rings with endothelium, an effect which was suppressed by N G-nitro-L-arginine methylester (L-NAME), nitric oxide (NO) scavenger, guany late cyclase inhibitor, endothelium denudation, and removal of Ca2+. L-NAME contracted, and superoxide dismutase relaxed, the arteries only when the e ndothelium was preserved. Neither superoxide dismutase nor P-adrenoceptor a ntagonists changed celiprolol-induced relaxations. Celiprolol increased the cyclic GMP content in the tissue. The release of NO from endothelium, esti mated by the extracellular production of cyclic GMP in arteries incubated i n medium containing guanylate cyclase and GTP, was augmented by celiprolol, and L-NAME abolished this action of celiprolol. It is concluded that celip rolol elicits relaxation by acting on sites other than P-adrenoceptors in t he endothelium and by releasing NO, which activates soluble guanylate cycla se in smooth muscle and produces cyclic GMP. Scavenging of superoxide anion s from the endothelium does not seem to account for the induced relaxation. (C) 2001 Elsevier Science B.V. All rights reserved.